ClinicalTrials.Veeva

Menu

Postoperative Sore Throat: Interest of the Videolaryngoscope

M

Mongi Slim Hospital

Status

Completed

Conditions

Postoperative Pain
Sore-throat
Tracheal Intubation Morbidity
Anesthesia

Treatments

Procedure: tracheal intubation by Videolaryngoscope
Procedure: tracheal intubation by direct laryngoscope

Study type

Interventional

Funder types

Other

Identifiers

NCT05614414
Sore throat videolaryngoscope

Details and patient eligibility

About

Postoperative sore throat is a complication of orotracheal intubation. The aim of our study was to assess the impact of videolaryngoscopy on postoperative sore throat during the first 24 hours following surgery.

This was a prospective, randomized study, over a period of 9 months. The investigators included 136 patients with non-difficult airway, classified ASA I to III and over 18 years old. The patients were randomized into 2 groups: the VL group including 70 patients intubated with direct laryngoscopy and the LD group including 66 patients intubated with videolaryngoscopy.

Full description

The investigators monitored blood pressure, ECG, saturation in oxygen, capnograph, temperature and curarization. They also monitored cuff pressure using manometer.

The investigators pre-oxygenated the patients until the fractional expired oxygen was over 90%, then induced anaesthesia using either 2.5 to 3.5 mg/kg of propofol or 0.3 to 0.4 mg/kg of etomidate, then 1mg/kg of suxamethonium (in absence of contraindication). If modified crash induction was performed, the anaesthesiologist mentioned the opioid used.

The investigators performed laryngoscopy using either a Macintosh laryngoscope using a number 4 blade in LD group, or a McGrath video-laryngoscope with a number 4 blade in VL group and a stylet when needed. Women were intubated using number 7 tube and man using a 7.5 tube. They inflated the cuff with 7ml of air, and controlled pressure by manometer every 30 minutes in order to maintain it between 20 and 25 mmHg.

The investigators ventilated patients with assisted controlled mode using a 6ml/kg of ideal weight volume, a 6 mmHg PEEP, a 50% inspired fraction of oxygen and a respiratory rate guaranteeing an end-expiratory CO2 level between 35 and 40 mmHg. Then, they administrated 4 mg of Ondansetran in order to prevent postoperative nausea and vomiting (PONV).

The investigators maintained anaesthesia using either isoflurane or sevoflurane, 0.1 μg/kg of sufentanil and 0.05 mg/kg of atracurium.

Enrollment

135 patients

Sex

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients aged over 18 years old;
  • Patients with ASA status 1, 2 or 3;
  • Patients who underwent surgery with general anaesthesia and intubation;
  • written consent.

Exclusion criteria

  • Patients under corticosteroids;
  • Pregnant women;
  • Patient with at least two difficult intubation criteria or a limited mouth opening (under 2cm), difficult airway management history, upper airway tumour or cervical rachis trauma;
  • Patients who had an otorhinolaryngologic infection in the last month, an intubation or endoscopy of upper airway in the last 48 hours, vomiting in the last 24 hours, a gastric tube in the last 24 hours or throat symptoms prior to surgery;
  • Patients scheduled for a surgery implying a manipulation of upper airways;
  • Patient scheduled for a surgery > 2 hours.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

135 participants in 2 patient groups

VL Group
Experimental group
Description:
Patients who were intubated by videolaryngoscope.
Treatment:
Procedure: tracheal intubation by Videolaryngoscope
LD Group
Active Comparator group
Description:
Patients who were intubated by direct laryngoscope
Treatment:
Procedure: tracheal intubation by direct laryngoscope

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems